Add BrightSurf on Google Email

Science News Archive 2025 - Page 129


Page 129 of 574

Massey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphoma

VCU Massey Comprehensive Cancer Center is the first US site to enroll patients in a global Phase 2a clinical trial of PTX-100, a small molecule inhibitor for cutaneous T-cell lymphoma. The trial aims to evaluate the efficacy and safety of PTX-100 in patients with relapsed or refractory disease.

SourceVirginia Commonwealth University·TypeRandomized controlled/clinical trial·DateJul 24, 2025

Deep learning-based structural characterization and mass transport analysis of CO2 reduction catalyst layers

A new study uses deep learning to map microscopic structures and simulate mass transport in CO₂RR catalyst layers, providing a scalable blueprint for industrial CO₂ electrolyzers. By optimizing catalyst layer composition, high current densities can be sustained without sacrificing selectivity or durability.

SourceHigher Education Press·JournalFrontiers in Energy·TypeExperimental study·DateJul 24, 2025

Antibiotic-resistant bacteria found in southern ocean

Researchers discovered antibiotic-resistant Staphylococcus saprophyticus in the Southern Ocean, showing complete resistance to multiple antibiotics. The study highlights the need for greater awareness of human impact on pristine ecosystems like Antarctica, which may exacerbate public health issues through the food chain.

SourceHigher Education Press·JournalSystems Microbiology and Biomanufacturing·TypeExperimental study·DateJul 24, 2025

Reliance on administrative billing codes to track medical conditions can lead to high diagnostic error rates

Researchers found that billing codes may mistakenly identify diseases in up to 45% of cases, highlighting a significant limitation in using administrative data for clinical research. The study examined records of 1.36 million patients and found discrepancies between coded diagnoses and actual disease presence.

Study shows DNA regulatory switch prompts stem cells to give rise to blood

A new study has found that TAF1 operates as a key molecular switch in adult hematopoietic stem cell maintenance and lineage commitment. This discovery challenges prevailing models of gene regulation and has the potential to lead to new therapeutic strategies targeting the molecule, which could improve blood production and transplantation.

SourceUniversity of Miami Miller School of Medicine·JournalDevelopmental Cell·DateJul 24, 2025

Answer ALS Launches AI drug development collaboration with Tulane, Pennington Biomedical Research Center and GATC Health to advance ALS treatment discovery

Answer ALS is launching a groundbreaking collaboration with Tulane University and the Pennington Biomedical Research Center to harness AI for ALS treatment discovery. The Louisiana AI Drug Development Infrastructure for ALS (LADDIA) will prioritize therapeutic targets using AI-driven insights from the Answer ALS' Neuromine Data Portal.

Improving colorectal cancer prevention and treatment for Black Americans

Colorectal cancer claims more lives in Black communities than any other racial group, with incidence and mortality rates about 20% and 30% higher respectively. A new review by UCLA researchers highlights the need for equal access to screening, diagnosis, and treatment to eliminate these disparities.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Reviews Gastroenterology & Hepatology·DateJul 24, 2025

Astronomers discover star-shredding black holes hiding in dusty galaxies

Researchers have discovered star-shredding black holes in dusty galaxies, confirming that these events are powered by dormant black hole accretion. The study uses the James Webb Space Telescope to detect clear fingerprints of black hole activity in four galaxies, revealing key differences between active and dormant black holes.

SourceMassachusetts Institute of Technology·JournalThe Astrophysical Journal Letters·DateJul 24, 2025

Shedding light on why immunotherapy sometimes fails

Researchers found that certain antibodies can reduce antitumor immune cells, highlighting the need to consider ADCC activity when designing or selecting ICI therapeutics. This study could help improve cancer treatment by engineering antibodies that avoid damaging essential immune cells.

SourceChiba University·JournalInternational Journal of Pharmaceutics·TypeExperimental study·DateJul 24, 2025

New study reveals critical link between neighborhood violence, youth fighting, and perceived firearm availability

A new study reveals a significant association between neighborhood firearm violence exposure and adolescents' perceived ability to obtain a firearm outside the home. Fighting behavior was found to mediate 32% of the relationship, highlighting the layered risks faced by youth in high-violence settings.

SourceUniversity of Pennsylvania School of Nursing·JournalAmerican Journal of Preventive Medicine·DateJul 24, 2025

Breakthrough engineered enzyme for recycling of PET bottle and blended fibers at moderate temperatures

Researchers have engineered a novel enzyme, PET2-21M, to enhance the biodegradation of bottle-grade polyethylene terephthalate (PET) plastics. This breakthrough offers a sustainable and efficient alternative to conventional recycling processes, achieving significant improvements in catalytic activity and substrate efficiency.

SourceNational Institutes of Natural Sciences·JournalACS Sustainable Chemistry & Engineering·TypeExperimental study·DateJul 24, 2025

Highly thermal conductive and electromagnetic shielding polymer nanocomposites from waste masks

Researchers have developed a novel polymer nanocomposite from COVID-19 waste masks, achieving record-high thermal conductivity and electromagnetic shielding. The closed-loop upcycling strategy reduces environmental impact and cost, paving the way for sustainable electronics and circular economy applications.

SourceShanghai Jiao Tong University Journal Center·JournalNano-Micro Letters·TypeExperimental study·DateJul 24, 2025

Lipidomics study identifies cardiolipin dysregulation as a potential therapeutic target for bortezomib-induced peripheral neuropathy

A groundbreaking study found significant mitochondrial cardiolipin dysregulation in patients with bortezomib-induced peripheral neuropathy. The researchers identified diosmin as a promising candidate for targeting this condition, providing new avenues for therapeutic intervention.

SourceFAR Publishing Limited·JournalCurrent Pharmaceutical Analysis·DateJul 24, 2025

Can proactive assisted gene flow save Caribbean and Floridian corals?

Coral reefs face severe threats from climate change and heat stress. Researchers are turning to assisted gene flow (AGF) to restore genetic diversity and boost resilience. International collaboration and revisions to conservation laws are necessary to proactively expand AGF efforts, safeguarding and restoring coral reef ecosystems.

Study finds large language models (LLMs) use stigmatizing language about individuals with alcohol and substance use disorders

A new study by Mass General Brigham found that over 35% of responses from large language models contained stigmatizing language related to alcohol- and substance use-related conditions. However, targeted prompts can reduce this language substantially. The authors recommend using patient-centered language to build trust with patients.

SourceMass General Brigham·JournalJournal of Addiction Medicine·TypeRandomized controlled/clinical trial·DateJul 24, 2025

Fully π-conjugated carbon nanobelts: Synthetic breakthroughs and electronic innovation

Researchers from NUS develop non-alternant carbon nanobelts featuring five-membered cyclopentadienyl units, allowing for improved electron flow and new electronic properties. The novel structures emit bright red light and exhibit small energy gaps, making them suitable for organic light-emitting diodes and solar cells.

SourceNational University of Singapore·JournalNature Synthesis·TypeExperimental study·DateJul 24, 2025

Protecting immune cells from exhaustion

A team of researchers led by Simona Stäger identified IRF-5 as a guardian of T cell metabolism and mitochondrial function. The discovery provides new strategies for boosting immunity to chronic infections or cancers, where T cell exhaustion is observed. IRF-5's role in preserving immune cell energy could play a key role in this approach.

SourceInstitut national de la recherche scientifique - INRS·JournalThe EMBO Journal·TypeNews article·DateJul 24, 2025

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

Researchers at Fox Chase Cancer Center have provided a detailed assessment of how fast breast cancers grow in patients and how surgical delays may affect breast cancer staging. The study found that upstaging rates associated with delays are relatively small and consistent with prior data.

SourceTemple University Health System·JournalAnnals of Surgical Oncology·TypeData/statistical analysis·DateJul 24, 2025